Perrigo
PRGO
$41.21
Share price
2.23%
Change (1 day)
-10.47%
Change (1 year)
Categories
Revenue for Perrigo (PRGO)
Revenue in 2022 (TTM): $4.20 B
According to Perrigo's latest financial reports the company's current revenue (TTM) is $4.20 B. In 2021 the company made a revenue of $4.13 B a decrease over the years 2020 revenue that were of $5.06 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Perrigo from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $4.20 B | 1.56% |
| 2021 | $4.13 B | -18.26% |
| 2020 | $5.06 B | 4.67% |
| 2019 | $4.83 B | 2.23% |
| 2018 | $4.73 B | -4.34% |
| 2017 | $4.94 B | -6.33% |
| 2016 | $5.28 B | -1.3% |
| 2015 | $5.35 B | 28.25% |
| 2014 | $4.17 B | 9.8% |
| 2013 | $3.79 B | 16.46% |
| 2012 | $3.26 B | 10.23% |
| 2011 | $2.95 B | 17.61% |
| 2010 | $2.51 B | 18.41% |
| 2009 | $2.12 B | 3.89% |
| 2008 | $2.04 B | 31.57% |
| 2007 | $1.55 B | 11.2% |
| 2006 | $1.39 B | 14.23% |
| 2005 | $1.22 B | 32.65% |
| 2004 | $0.92 B | 9.83% |
| 2003 | $0.84 B | 2.3% |
| 2002 | $0.82 B | 0.76% |
| 2001 | $0.81 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 United Therapeutics UTHR | $1.75 B | -58.17% | 🇺🇸 USA |
 Endo International
ENDP | $2.92 B | -30.35% | 🇮🇪 Ireland |
 Intercept Pharmaceuticals
ICPT | $0.37 B | -91.19% | 🇺🇸 USA |
 Catalent CTLT | $4.70 B | 11.90% | 🇺🇸 USA |